PRRT2 and cancer: Thr567 was shown to be phosphorylated by the serine/threonine kinase Protein Kinase C (PKC) in vitro [36] and in response to PKC activation by phorbol 12-myristate 13-acetate (PMA) treatment in cancer cells [37], but not in a purely physiological context.